Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis

NCT02416102 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Difficulty in recruitment

Conditions

COPD
Chronic Bronchitis

Interventions

DRUG: Losartan 50 mg
DRUG: Losartan 100 mg

Sponsor

University of Miami

Collaborators

[object Object]
[object Object]